These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 32669326)

  • 41. New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models.
    Bricker KM; Chahroudi A; Mavigner M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species.
    Barry AP; Silvestri G; Safrit JT; Sumpter B; Kozyr N; McClure HM; Staprans SI; Feinberg MB
    J Immunol; 2007 Jun; 178(12):8002-12. PubMed ID: 17548637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques.
    Khowawisetsut L; Pattanapanyasat K; Onlamoon N; Mayne AE; Little DM; Villinger F; Ansari AA
    PLoS One; 2013; 8(4):e61264. PubMed ID: 23620737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence.
    Strongin Z; Hoang TN; Tharp GK; Rahmberg AR; Harper JL; Nguyen K; Franchitti L; Cervasi B; Lee M; Zhang Z; Boritz EA; Silvestri G; Marconi VC; Bosinger SE; Brenchley JM; Kulpa DA; Paiardini M
    PLoS Pathog; 2022 Jul; 18(7):e1010723. PubMed ID: 35867722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration.
    Chaudhary O; Narayan V; Lelis F; Linz B; Watkins M; Veazey R; Aldovini A
    PLoS Pathog; 2018 Aug; 14(8):e1007268. PubMed ID: 30161247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates.
    Yamada Y; Aoyama A; Tocco G; Boskovic S; Nadazdin O; Alessandrini A; Madsen JC; Cosimi AB; Benichou G; Kawai T
    J Immunol; 2012 Jun; 188(12):6063-70. PubMed ID: 22586034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.
    Bruel T; Hamimi C; Dereuddre-Bosquet N; Cosma A; Shin SY; Corneau A; Versmisse P; Karlsson I; Malleret B; Targat B; Barré-Sinoussi F; Le Grand R; Pancino G; Sáez-Cirión A; Vaslin B
    J Virol; 2015 Apr; 89(7):3542-56. PubMed ID: 25589645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
    Varco-Merth B; Chaunzwa M; Duell DM; Marenco A; Goodwin W; Dannay R; Nekorchuk M; Shao D; Busman-Sahay K; Fennessey CM; Silipino L; Hull M; Bosche WJ; Fast R; Oswald K; Shoemaker R; Bochart R; MacAllister R; Labriola CS; Smedley JV; Axthelm MK; Davenport MP; Edlefsen PT; Estes JD; Keele BF; Lifson JD; Lewin SR; Picker LJ; Okoye AA
    PLoS Pathog; 2024 Aug; 20(8):e1012496. PubMed ID: 39173097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin.
    Wang Z; Navarro-Alvarez N; Shah JA; Zhang H; Huang Q; Zheng Q; Madsen JC; Sachs DH; Huang CA; Wang Z
    Vet Immunol Immunopathol; 2016 Dec; 182():150-158. PubMed ID: 27863545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques.
    Vassena L; Miao H; Cimbro R; Malnati MS; Cassina G; Proschan MA; Hirsch VM; Lafont BA; Morre M; Fauci AS; Lusso P
    PLoS Pathog; 2012; 8(4):e1002636. PubMed ID: 22511868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis.
    Calascibetta F; Micci L; Carnathan D; Lawson B; Vanderford TH; Bosinger SE; Easley K; Chahroudi A; Mackel J; Keele BF; Long S; Lifson J; Paiardini M; Silvestri G
    J Virol; 2016 Aug; 90(16):7541-7551. PubMed ID: 27279614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
    Weiss L; Piketty C; Assoumou L; Didier C; Caccavelli L; Donkova-Petrini V; Levy Y; Girard PM; Burgard M; Viard JP; Rouzioux C; Costagliola D;
    PLoS One; 2010 Jul; 5(7):e11659. PubMed ID: 20657770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection.
    Nigam P; Kwa S; Velu V; Amara RR
    J Immunol; 2011 Jan; 186(2):745-53. PubMed ID: 21148794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques.
    Moniuszko M; Edghill-Smith Y; Venzon D; Stevceva L; Nacsa J; Tryniszewska E; Tsai WP; Franchini G
    Virology; 2006 Dec 5-20; 356(1-2):188-97. PubMed ID: 16934309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys.
    Pereira LE; Villinger F; Onlamoon N; Bryan P; Cardona A; Pattanapanysat K; Mori K; Hagen S; Picker L; Ansari AA
    J Virol; 2007 May; 81(9):4445-56. PubMed ID: 17314162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory T Cells As Potential Targets for HIV Cure Research.
    Kleinman AJ; Sivanandham R; Pandrea I; Chougnet CA; Apetrei C
    Front Immunol; 2018; 9():734. PubMed ID: 29706961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The split personality of regulatory T cells in HIV infection.
    Chevalier MF; Weiss L
    Blood; 2013 Jan; 121(1):29-37. PubMed ID: 23043072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell subset differentiation and antibody responses following antiretroviral therapy during simian immunodeficiency virus infection.
    Bhattacharyya M; Whitney JB; Seaman M; Barouch DH; Penaloza-MacMaster P
    Immunology; 2018 Dec; 155(4):458-466. PubMed ID: 30014618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8
    McBrien JB; Mavigner M; Franchitti L; Smith SA; White E; Tharp GK; Walum H; Busman-Sahay K; Aguilera-Sandoval CR; Thayer WO; Spagnuolo RA; Kovarova M; Wahl A; Cervasi B; Margolis DM; Vanderford TH; Carnathan DG; Paiardini M; Lifson JD; Lee JH; Safrit JT; Bosinger SE; Estes JD; Derdeyn CA; Garcia JV; Kulpa DA; Chahroudi A; Silvestri G
    Nature; 2020 Feb; 578(7793):154-159. PubMed ID: 31969705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.